Article Sidebar
Views PDF: 1161
DYSLIPIDEMIA STATUS AND CARDIOVASCULAR RISKS IN TYPE 2 DIABETES MELLITUS PATIENTS
Main Article Content
Abstract
Objective: To investigate the dyslipidemia status and stratification of cardiovascular risks caused by dyslipidemia in type 2 diabetes mellitus patients. Subjects and methods: Desciptive, cross-sectional study was conducted in 120 patients with diagnosis of type 2 diabetes mellitus from 12/2020 to 04/2021 at Nghe An endocrinology Hospital that to investigate bilan of lipidemia and stratifying cardiovascular risk. Results: Among the study subjects, there were 75,8% of them who were diagnosed with dyslipidemia, in detail, one component and multi-component dyslipidemia accounted for 22,5% and 53,3% respectively. With respect to dyslipidemia components, hypercholesterol occupied the highest proportion (55,0%), then hypertriglycerid (39,2%), hyper-LDL-C (31,7%), HDL-C occupied the lowest proportion (22,5%). The proportion of patients with dyslipidemia in ≥ 7mmol/l glycemia group was higher than that in < 7mmol/l glycemia group (p<0,05). Mean 10-year cardiovascular risk according to Framingham score was 12,25±8,49% with low risk patients accounted for 39,2%, medium risk: 43,3% and high risk: 17,5%. Conclusion: The proportion of type 2 Diabetes mellitus patients diagnosed with dyslipidemia was high. There was a correlation between dyslipidemia status and fasting glycemia. 10-year cardiovascular risk according to Framingham score was high.
Article Details
Keywords
Type 2 Diabetes mellitus, Dyslipidemia, Framingham score
References
2. Viên Quang Mai, Nguyễn Văn Đạt, Đỗ Thái Hùng (2017), Tỷ lệ và các yếu tố liên quan đến rối loạn lipid máu ở người > 45 tuổi bị đái tháo đường type 2 và tiền đái tháo đường mới được phát hiện tại tỉnh Khánh Hòa. Tạp chí Y học dự phòng;8:288.
3. Trần Thừa Nguyên, Phạm Minh (2020), Dự báo nguy cơ bệnh mạch vành trong 10 năm tới theo thang điểm Framingham ở bệnh nhân Đái tháo đường typ 2. Tạp chí Nội tiết và Đái tháo đường;44:33–41.
4. Trương Thanh Sơn, Nguyễn Văn Trí, Trương Quang Bình (2011). Nghiên cứu áp dụng thang điểm Framingham nhằm lượng định nguy cơ bệnh động mạch vành trong 10 năm tới tại bệnh viện đa khoa tỉnh Bình Dương. Tạp chí Y học Thành phố Hồ Chí Minh;15(1):207–11.
5. Ahmmed MS, Shuvo S Das, Paul DK, Karim MR, Kamruzzaman M, Mahmud N, et al (2021), Prevalence of dyslipidemia and associated risk factors among newly diagnosed Type-2 Diabetes Mellitus (T2DM) patients in Kushtia, Bangladesh. PLOS Glob Public Heal [Internet];1(12):e0000003. Available from: http://dx.doi.org/10.1371/journal.pgph.0000003
6. Haile K, Timerga A (2020), Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at jimma university medical center, Jimma, Southwest Ethiopia. Diabetes, Metab Syndr Obes Targets Ther;13:4589–97.
7. Jahangiry L, Farhangi MA, Rezaei F (2017), Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Heal Popul Nutr; 36(1):1–6.
8. Thapa SD, K.C SR, Gautam S, Gyawali D (2017), Dyslipidemia in Type 2 Diabetes mellitus. J Pathol Nepal;7(2):1149–54.